Shares in Aquestive Therapeutics (NSDQ:AQST) rose today after the company announced FDA approval for its Sympazan oral film for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome. The clobazam oral film is the first product of its kind to be approved by the FDA as a treatment for seizures associated with LGS, according to Aquestive. Clobazam […]
NIH invests over $220M in BRAIN initiative
The National Institutes of Health announced today that it is funding more than 200 new awards, totaling over $220 million in investments, through the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. Some of the new awards include the creation of a wireless optical tomography cap for scanning human brain activity; a noninvasive brain-computer interface […]
Abiomed joins Protembis $10m Series A
Protembis said today it closed a $10 million Series A round, joined by cardiovascular device-focused Abiomed (NSDQ:ABMD), to support its embolic cerebral protection device. The round was joined by Abiomed, Aachen and Mönchengladbach GmbH’s Seed Fonds III and a number of family offices and angel investors, the Aachen, Germany-based company said. “Patient safety should always be our […]
The top 10 medical disruptors of 2019
The Cleveland Clinic for the past 16 years has predicted what the top 10 medical disruptors will be for the following year. The health provider seeks input from 150 to 200 of its physicians, hailing from each of its institutes. The result is 300 to 400 suggestions, which the clinic then narrows down to 150. […]
Novocure touts results from glioblastoma TTF trial analysis
NovoCure (NSDQ:NVCR) yesterday released results from a post-hoc analysis of its EF-14 phase 3 pivotal trial in newly diagnosed glioblastoma, touting an association between higher doses of Tumor Treating Fields and improved overall survival. The analysis explored patient data from 317 qualified individuals in the TTF treatment arm of the St. Helier, Jersey-based company’s EF-14 phase […]
Monteris wins FDA nod for NeuroBlate Optic laser probe
Monteris Medical said today it won FDA clearance for the NeuroBlate Optic laser probe designed for its minimally invasive magnetic resonance imaging-guided NeuroBlate robotic laser thermotherapy system, which is intended for use in treating brain tumors and epileptic foci. The Plymouth, Minn.-based company said that the newly cleared laser probe replaces previous generation’s metal thermocouple inside […]
Feinstein researchers study what the body is telling the brain
A 2014 study showed that inflammation-causing proteins known as cytokines were present in the plasma of lupus patients up to several weeks before their disease flared up. Conversely, these Oklahoma researchers found that inflammation regulators are present during periods when the disease is stable. Now, researchers at The Feinstein Institute for Medical Research (Manhasset, N.Y.) are working […]
Report: Nevada’s Heller pushed unapproved TMS treatment on VA
Nevada Senator Dean Heller (R-NV) encouraged doctors at a Reno-based Veterans Affairs medical center to use an off-label transcranial magnetic stimulation technology marketed by a company with connections to his office, according to a new ProPublica report. The company, called CereCare, markets a technology it says uses electrical scans of the brain and heart to […]
Minnetronix Neuro inks Neurapheresis Consortium deal with Duke
Minnetronix Medical’s Neuro division said today it joined with Duke University to co-found The Neurapheresis Consortium, which aims to accelerate the advancement of Neurapheresis Therapy intended to treat patients with diseases affecting the central nervous system. The company’s Neurapheresis therapy system is a minimally invasive platform which includes a dual lumen catheter designed to be […]
InVivo inks joint research deal with cell therapy dev Q Therapeutics
InVivo Therapeutics (NSDQ:NVIV) said today it inked a joint research agreement with clinical-stage central nervous system cell therapy developer Q Therapeutics. Through the deal, InVivo is looking to combine its neuro-spinal scaffold technology with Q Therapeutics’ adult neural progenitor cells, Cambridge, Mass.-based InVivo said. Both companies will share their technologies and explore the potential combination’s safety […]
Insightec touts another CMS win for MR-guided focused ultrasound
Insightec said today it won Medicare benefit coverage from CGS Medicare and Palmetto GBA for procedures using its Neuravive MR-guided focused ultrasound system to treat essential tremor. The Israel-based company said that with the addition, 25 states now cover its Neuravive treatment for medication-refractory essential tremor. “2018 marks the year of Medicare reimbursement for incisionless focused […]
- 1
- 2
- 3
- …
- 57
- Next Page »
MassDevice Network
@MassDevice
LinkedIn